Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

L.A. McKeown

December 09, 2024

News Daily News

Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks

L.A. McKeown

January 24, 2024

News Daily News

Optimal Care Reported in Less Than Half of Adults With ASCVD

Yael L. Maxwell

December 05, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

More Data Show Redlining’s Lasting Impact on CVD Risk

L.A. McKeown

July 14, 2023

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

Caitlin E. Cox

June 14, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for January

Todd Neale

January 01, 2021

News Daily News

Payments to Docs Appear to Influence Implantable Device Selection

Michael O'Riordan

November 04, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

News Opinion Off Script

COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?

Asif Qasim, MB BChir, PhD

March 06, 2020

News Daily News

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

Todd Neale

February 04, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Michael O'Riordan

December 03, 2019

Advertisement

Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple

Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks

Optimal Care Reported in Less Than Half of Adults With ASCVD

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

More Data Show Redlining’s Lasting Impact on CVD Risk

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Minorities, Poorer Patients Missing Out on Structural Heart Care

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

COVID-19: TCTMD’s Daily Dispatch for January

Payments to Docs Appear to Influence Implantable Device Selection

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Remdesivir Study for COVID-19 Yields Positive Top-line Results

COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?

Coronavirus: CV Meeting Planners Keeping an Eye on Evolving Situation

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content